BioBoyScout
Subscribe
Sign in
Home
White Papers
Notes
Disclosures
About
Latest
Top
Discussions
Nobody Gets to Wait
Arrowhead proved a shot can silence a gene in the human brain. The proof was expensive to produce and it is free to read.
Nov 1
•
BioBoyScout
4
October 2026
Nobody Else Has a Key
Everyone wants a way into the brain without a spinal needle. Arrowhead is the first to show what subcutaneous RNAi can do in a person.
Oct 26
•
BioBoyScout
8
The Check Has Not Been Played
My Forced Move papers named two events: a gate the thesis had to survive and a check that starts the cascade. Only one has happened.
Oct 21
•
BioBoyScout
2
The Liver Got Paid
Small trials, enormous moves. The liver was rewarded and punished in double digits. Arrowhead reached the brain and closed up 0.41 percent.
Oct 18
•
BioBoyScout
8
2
The Bishop Moved
Arrowhead silenced a gene in the human brain with a shot under the skin. The number is 73 percent. The interesting parts are when, and where.
Oct 14
•
BioBoyScout
5
2
2
Ninety-Eight Percent of Nothing
Two tau drugs produced impressive numbers. The field read both of them wrong. What to watch on October 14.
Oct 11
•
BioBoyScout
3
4
The Increment
The FDA built a faster review lane four years ago and almost nobody used it. Arrowhead just walked in, and kept the voucher it bought for speed.
Oct 7
•
BioBoyScout
4
Out of Book
New siRNA companies are signing billion-dollar deals. The published playbook gets them into the liver. Past it, they have to earn their way.
Oct 4
•
BioBoyScout
5
September 2026
The Long Diagonal
Arrowhead's brain drug is aimed at Alzheimer's. The webinar agenda hints the fastest road there may run through rarer diseases.
Sep 29
•
BioBoyScout
5
Nobody Sells for Seven Percent
Goldman Sachs gets almost everything right about Arrowhead. Then its theoretical acquisition value lands below the stock's own fifty-day average.
Sep 24
•
BioBoyScout
5
1
1
Opening Preparation
Arrowhead put eighteen drugs into human trials between 2017 and 2023, and has kept going since. That is one every four months, and it is not because…
Sep 23
•
BioBoyScout
2
1
The Seconds
Arrowhead has RNAi drugs in six tissues, five by a shot under the skin. Nobody else comes close. This is about why everyone else stayed put, and about…
Sep 21
•
BioBoyScout
3
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts